Kongenitale Muskeldystrophie und kongenitale Myopathie von Roy Strowd, MD

video locked

Über den Vortrag

Der Vortrag „Kongenitale Muskeldystrophie und kongenitale Myopathie“ von Roy Strowd, MD ist Bestandteil des Kurses „Erbliche neuromuskuläre Erkrankungen“.


Quiz zum Vortrag

  1. Patients with congenital muscular dystrophy will have progressively worsening symptoms.
  2. Patients with congenital myopathy will have progressively worsening symptoms.
  3. A biopsy of congenital myopathy will show muscle necrosis.
  4. Patients with congenital muscular dystrophy will have static or very slowly progressive symptoms.
  5. Only congenital muscular dystrophy is related to a genetic error.
  1. Babies presenting with severe weakness, mental retardation, and seizures should be screened for congenital muscular dystrophy.
  2. Genetic testing is not useful in determining a congenital muscular dystrophy diagnosis.
  3. Facial or ocular symptoms are extremely rare in these diseases.
  4. All congenital muscular dystrophies are related to mutations in the same gene.
  5. Patients will generally improve with time.
  1. These conditions can be differentiated by pathological examination of histological features.
  2. These diseases are present at birth and continue to worsen with time.
  3. Muscle cell death is pathognomonic for congenital myopathy.
  4. These diseases have no known genetic mutation.
  5. Function of the living muscle cells is considered normal.
  1. Treatment options do not exist for either of these diseases.
  2. Only congenital myopathy can be diagnosed through genetic testing.
  3. Only congenital muscular dystrophy disorders are static over time.
  4. Only congenital myopathy disorders are present at birth.
  5. Both of these disorders carry a worse prognosis for boys.

Dozent des Vortrages Kongenitale Muskeldystrophie und kongenitale Myopathie

 Roy Strowd, MD

Roy Strowd, MD

Dr. Roy Strowd is the Assistant Dean of Undergraduate Medical Education at the Wake Forest Baptist Medical Center, in North Carolina, USA.
He obtained his MD from Wake Forest School of Medicine in 2009, and his MEd from Johns Hopkins University in 2021. Currently, he co-directs the Neurofibromatosis and Tuberous Sclerosis Clinics at Wake Forest Baptist Medical Center, and is a researcher for the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology.
Due to his achievements, he earned the M. Brownell Anderson Award from the Association of American Medical Colleges.
Within Lecturio, Dr. Strowd teaches courses on Clinical Neurology.


Kundenrezensionen

(1)
5,0 von 5 Sternen
5 Sterne
5
4 Sterne
0
3 Sterne
0
2 Sterne
0
1  Stern
0